Compounds > 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Hyperlipemia

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Hyperlipemia in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's3 (60.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, R; Febbraio, M; Liu, J; Marathe, GK; McIntyre, TM; Zou, W1
Egashira, T; Hattori, H; Ishi, J; Ishihara, M; Ito, M; Iwasaki, T; Kawaguchi, A; Kujiraoka, T; Miller, NE; Nagano, M; Stepanova, IP; Takahashi, S; Tsuji, M1
Angeli, V; Fisher, EA; Ishii, S; Llodrá, J; Randolph, GJ; Rong, JX; Satoh, K; Shimizu, T1
Antonopoulou, S; Demopoulos, CA; Iliopoulos, DG; Karantonis, HC; Kavantzas, N; Perrea, DN; Sokolis, DP; Theocharis, SE1
Diamond, JR; Kees-Folts, D1

Reviews

1 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Hyperlipemia

ArticleYear
Relationship between hyperlipidemia, lipid mediators, and progressive glomerulosclerosis in the nephrotic syndrome.
    American journal of nephrology, 1993, Volume: 13, Issue:5

    Topics: Animals; Eicosanoids; Glomerulosclerosis, Focal Segmental; Humans; Hyperlipidemias; Macrophages; Nephrotic Syndrome; Platelet Activating Factor; Transforming Growth Factor beta

1993

Other Studies

4 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Hyperlipemia

ArticleYear
Circulating platelet-activating factor is primarily cleared by transport, not intravascular hydrolysis by lipoprotein-associated phospholipase A2/ PAF acetylhydrolase.
    Circulation research, 2011, Feb-18, Volume: 108, Issue:4

    Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Animals; Apolipoproteins E; Biological Transport; Cells, Cultured; Disease Models, Animal; Endothelium, Vascular; Humans; Hydrolysis; Hyperlipidemias; Mice; Mice, Inbred C57BL; Mice, Knockout; Phospholipids; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled

2011
Altered distribution of plasma PAF-AH between HDLs and other lipoproteins in hyperlipidemia and diabetes mellitus.
    Journal of lipid research, 2003, Volume: 44, Issue:10

    Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Antibodies, Monoclonal; Apoproteins; Base Sequence; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus; Enzyme-Linked Immunosorbent Assay; Female; Genetic Techniques; Humans; Hyperlipidemias; Lipoproteins; Male; Middle Aged; Molecular Sequence Data; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Triglycerides

2003
Dyslipidemia associated with atherosclerotic disease systemically alters dendritic cell mobilization.
    Immunity, 2004, Volume: 21, Issue:4

    Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Animals; Apolipoproteins E; Arteriosclerosis; Cell Movement; Cholesterol, HDL; Dendritic Cells; Female; Humans; Hyperlipidemias; Immunohistochemistry; Lipoproteins, LDL; Lymph Nodes; Male; Mice; Mice, Transgenic; Organ Culture Techniques; Platelet Activating Factor; Receptors, LDL; Reverse Transcriptase Polymerase Chain Reaction; Skin

2004
In vivo antiatherogenic properties of olive oil and its constituent lipid classes in hyperlipidemic rabbits.
    Nutrition, metabolism, and cardiovascular diseases : NMCD, 2006, Volume: 16, Issue:3

    Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Animals; Aorta; Atherosclerosis; Diet, Atherogenic; Disease Models, Animal; Hyperlipidemias; Lipoproteins; Male; Olive Oil; Oxidation-Reduction; Plant Oils; Platelet Activating Factor; Platelet Aggregation; Rabbits

2006